Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$972M |
| 4 |
NVIDIA
NVDA
|
+$894M |
| 5 |
Intel
INTC
|
+$766M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$565M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$563M |
| 3 |
Phillips 66
PSX
|
+$507M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
Palo Alto Networks
PANW
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Financials | 9.79% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
CRISPR Therapeutics
CRSP
$5.1B
| $1.84M | ﹤0.01% |
27,000
-25,000
| -48% | -$1.79M |
|
2602
RingCentral
RNG
$5.14B
| $1.84M | ﹤0.01% |
52,952
+21,874
| +70% | +$736K |
|
|
MRSN
2603
DELISTED
Mersana Therapeutics
MRSN
| $1.83M | ﹤0.01% |
16,369
+10,286
| +169% | +$1.02M |
|
2604
Collegium Pharmaceutical
COLL
$1.03B
| $1.83M | ﹤0.01% |
47,164
-25,568
| -35% | -$895K |
|
2605
Tronox
TROX
$1.04B
| $1.83M | ﹤0.01% |
105,525
-78,296
| -43% | -$1.14M |
|
2606
Genmab
GMAB
$18.1B
| $1.82M | ﹤0.01% |
61,005
+61,000
| +1,220,000% | +$1.79M |
|
2607
Liberty Live Group Series A
LLYVA
$9.23B
| $1.82M | ﹤0.01% |
43,066
-78,991
| -65% | -$2.95M |
|
2608
Photronics
PLAB
$1.87B
| $1.82M | ﹤0.01% |
64,399
-53,659
| -45% | -$1.6M |
|
|
CVSA
2609
Covista Inc
CVSA
$4.24B
| $1.82M | ﹤0.01% |
35,413
-31,167
| -47% | -$1.63M |
|
2610
StoneX
SNEX
$8.37B
| $1.82M | ﹤0.01% |
87,436
-72,853
| -45% | -$1.46M |
|
|
BBBY
2611
Bed Bath & Beyond
BBBY
$429M
| $1.82M | ﹤0.01% |
55,732
-38,262
| -41% | -$984K |
|
2612
N-able
NABL
$921M
| $1.82M | ﹤0.01% |
138,982
+5,805
| +4% | +$76.8K |
|
2613
CALL
KLA
KLAC
$249B
| $1.82M | ﹤0.01% |
26,000
-8,000
| -24% | -$514K |
|
|
AVDX
2614
DELISTED
AvidXchange
AVDX
| $1.82M | ﹤0.01% |
138,106
-96,543
| -41% | -$1.16M |
|
2615
Caleres
CAL
$471M
| $1.81M | ﹤0.01% |
44,206
-50,223
| -53% | -$1.75M |
|
2616
ADMA Biologics
ADMA
$2.34B
| $1.81M | ﹤0.01% |
274,049
-306,689
| -53% | -$1.68M |
|
|
AD
2617
Array Digital Infrastructure
AD
$3.08B
| $1.81M | ﹤0.01% |
49,533
-43,999
| -47% | -$1.72M |
|
2618
White Mountains Insurance
WTM
$5.31B
| $1.81M | ﹤0.01% |
1,007
-59
| -6% | -$98.9K |
|
2619
St. Joe Company
JOE
$3.69B
| $1.81M | ﹤0.01% |
31,159
-23,207
| -43% | -$1.28M |
|
|
FBMS
2620
DELISTED
The First Bancshares, Inc.
FBMS
| $1.8M | ﹤0.01% |
69,452
-4,489
| -6% | -$115K |
|
2621
Janus International
JBI
$762M
| $1.8M | ﹤0.01% |
119,041
-56,662
| -32% | -$824K |
|
|
PMT
2622
PennyMac Mortgage Investment
PMT
$822M
| $1.8M | ﹤0.01% |
122,525
-106,514
| -47% | -$1.52M |
|
2623
PUT
Microchip Technology
MCHP
$42.2B
| $1.79M | ﹤0.01% |
20,000
-80,000
| -80% | -$6.9M |
|
2624
On Holding
ONON
$12.6B
| $1.79M | ﹤0.01% |
50,674
-35,884
| -41% | -$1.1M |
|
2625
Clearway Energy Class C
CWEN
$5.13B
| $1.79M | ﹤0.01% |
77,761
+6,801
| +10% | +$160K |
|
Similar funds
Barclays's Q1 2024 Portfolio in Review
As of Q1 2024, Barclays held 5,511 positions worth $288B, up 5.5% from $273B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q1 2024 filing shows 303 new, 1,218 increased, 2,942 reduced and 472 closed positions. Its largest new stake was Flutter Entertainment: 1,101,287 shares worth $217M. The largest sale was Qualcomm, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q1 2024 buy was Flutter Entertainment: 1,101,287 shares worth $217M.
- Barclays added most to Apple in Q1 2024, an estimated $3.11B increase.
- Barclays's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $565M.
- Barclays fully exited Splunk Inc in Q1 2024, selling an estimated $210M.
- Barclays's ten largest holdings make up 29% of its $288B portfolio in Q1 2024.
- Barclays opened 303 new positions and closed 472 in Q1 2024.
- Barclays's portfolio value rose 5.5% quarter-over-quarter to $288B.
Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.